Understanding dopaminergic dose reduction following STN-DBS: mediation analysis.

Lanore A, Houot M, Basset A, Bendetowicz D, Menon PJ, Bardinet E, Fernandez Vidal S, Cornillault J, Karachi C, Navarro S, Ihle J, Eusebio A, Giordana C, Rouaud T, Drapier S, Guehl D, Marques A, Hubsch C, Jarraya B, Benatru I, Thobois S, Hopes L, Maltete D, Rascol O, Tir M, Moreau C, Tranchant C, Rolland AS, Devos D, Corvol JC, Grabli D, Hainque E, PREDISTIM study group

Open source

DOI: 10.1136/bmjno-2025-001427
Published: 2026
Container: BMJ neurology open
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1136/bmjno-2025-001427,
  title = {Understanding dopaminergic dose reduction following STN-DBS: mediation analysis.},
  author = {Lanore A and Houot M and Basset A and Bendetowicz D and Menon PJ and Bardinet E and Fernandez Vidal S and Cornillault J and Karachi C and Navarro S and Ihle J and Eusebio A and Giordana C and Rouaud T and Drapier S and Guehl D and Marques A and Hubsch C and Jarraya B and Benatru I and Thobois S and Hopes L and Maltete D and Rascol O and Tir M and Moreau C and Tranchant C and Rolland AS and Devos D and Corvol JC and Grabli D and Hainque E and PREDISTIM study group},
  year = {2026},
  journal = {BMJ neurology open},
  doi = {10.1136/bmjno-2025-001427},
  url = {https://doi.org/10.1136/bmjno-2025-001427}
}

RIS

TY  - JOUR
TI  - Understanding dopaminergic dose reduction following STN-DBS: mediation analysis.
AU  - Lanore A
AU  - Houot M
AU  - Basset A
AU  - Bendetowicz D
AU  - Menon PJ
AU  - Bardinet E
AU  - Fernandez Vidal S
AU  - Cornillault J
AU  - Karachi C
AU  - Navarro S
AU  - Ihle J
AU  - Eusebio A
AU  - Giordana C
AU  - Rouaud T
AU  - Drapier S
AU  - Guehl D
AU  - Marques A
AU  - Hubsch C
AU  - Jarraya B
AU  - Benatru I
AU  - Thobois S
AU  - Hopes L
AU  - Maltete D
AU  - Rascol O
AU  - Tir M
AU  - Moreau C
AU  - Tranchant C
AU  - Rolland AS
AU  - Devos D
AU  - Corvol JC
AU  - Grabli D
AU  - Hainque E
AU  - PREDISTIM study group
PY  - 2026
JO  - BMJ neurology open
DO  - 10.1136/bmjno-2025-001427
UR  - https://doi.org/10.1136/bmjno-2025-001427
ER  -

APA

A, L., M, H., A, B., D, B., PJ, M., E, B., S, F. V., J, C., C, K., S, N., J, I., A, E., C, G., T, R., S, D., D, G., A, M., C, H., B, J., I, B., S, T., L, H., D, M., O, R., M, T., C, M., C, T., AS, R., D, D., JC, C., D, G., E, H., & group, P. S. (2026). Understanding dopaminergic dose reduction following STN-DBS: mediation analysis.. BMJ neurology open. https://doi.org/10.1136/bmjno-2025-001427

Source records

pubmed · retrieved 2026-09-26T23:02:45.518Z